Using ruthenium-catalysed propargylic substitutions for the efficient syntheses of rotaxanes
作者:Yuji Tokunaga、Nobuhiko Kawai、Youji Shimomura
DOI:10.1016/j.tetlet.2007.05.116
日期:2007.7
This Letter describes an efficient method—one that takes advantage of hydrogen bond-guided self-assembly and ruthenium-catalysed propargylic substitution—for the preparation of rotaxanes. The substitution reactions of a pseudorotaxane with a diverse range of heteroatom- and carbon-atom-centred nucleophiles were catalysed by the [(Cp∗)RuCl(SMe)]2 complex to furnish rotaxanes in good yields.
This Letter describes an efficient method for constructing a C3-symmetric [4]rotaxane through hydrogen bond-guided self-assembly and boroxine formation. The reactions proceed under mild conditions in solution, with entropically driven forces promoting the formation of the [4]rotaxane.
Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones
申请人:AMERICAN HOME PRODUCTS CORPORATION
公开号:EP1151990A1
公开(公告)日:2001-11-07
The compounds of the formula:
wherein R1, R2, R3 and A are as defined herein are useful, via potassium channel modulation, in the treatment of disorders associated with smooth muscle contraction. Such disorders include, but are not limited to, urinary incontinence, hypertension, asthma, premature labor, irritable bowel syndrome, congestive heart failure, angina and cerebral vascular disease.
式中的化合物
其中 R1、R2、R3 和 A 如本文所定义,通过调节钾通道,可用于治疗与平滑肌收缩有关的疾病。这些疾病包括但不限于尿失禁、高血压、哮喘、早产、肠易激综合征、充血性心力衰竭、心绞痛和脑血管疾病。
Anxiolytic activity of analogues of 4-benzylamino-2-methyl-7H-pyrrolo[2,3-d]pyrimidines
作者:Eric A. Meade、Marcos Sznaidman、Gerald T. Pollard、Lilia M. Beauchamp、James L. Howard
DOI:10.1016/s0223-5234(98)80003-2
日期:1998.6
An extensive series of analogues of the lead anxiolytic 4-benzylamino-2-methylpyrrolo[2,3-d]pyrimidine 1 was synthesized and evaluated in the Geller-Seifter conflict test for anxiolytic activity to discover a less toxic derivative. Analysis of the SAR revealed that the most potent compounds were those with meta substituents on the benzylamino ring. In this group the most promising derivatives were 4-[bis(3,5-dimethylamino)]benzylamino-2-methyl-7H-pyrrolo[2,3-d]pyrimidine 12 and 4-(3,5-dimethylbenzylamino)-2-methyl-7H-pyrrolo [2,3-d]pyrimidine 24. Potential metabolites of 12 were synthesized and checked for their anxiolytic activity. Less toxic analogues of the second lead 24 were prepared by extending the alkyl groups attached to the benzene ring moiety. The addition of a fluoro substituent to the benzene moiety in the extended alkyl chain analogue 4-(3,5-diethyl-2-fluorobenzylamino)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine 34 resulted in a compound with a longer duration of activity relative to its analogue 4-(3,5-diethylbenzylamino)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine 26. (C) Elsevier, Paris.
Efficient Synthesis of [2]Rotaxanes Based on Sequential Acetylene-Dicobalt Hexacarbonyl Complexation and Stopper Modification
This paper describes an efficient end-capping method for the preparation of [2]rotaxanes, using acetylene-dicobalt hexacarbonyl complexation and subsequent transformation of the complexes into a series of vinylsilanes though hydrosilylation.